Blinatumomab is a very specialized and advanced drug, recommended in the management of complex Haematological malignancies. As per the FDA approval data, Blincyto was first approved for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia in adults and children. Its selective mechanism of action dictates the human immune system to target the malignant tumour cells. Later it was approved in the management of B-cell precursor ALL. It is now approved with orphan status to treat Diffuse Large B-cell Lymphoma. This is a monoclonal antibody that acts as bispecific T-cell engager (BiTE) antibody, highly desirable to treat specific type of ALL patients. Blinatumomab in India is sourced through legal channels of import.
Blincyto in India is also often recommended for the patients who are also ideal candidates for stem cell transplant. Dosage and administration guidelines would change according to the body weight and are different for adult and paediatric patients. In most of the adult patients, it is administered as continuous infusion for 28 days in a cycle. Patients who experienced positive outcomes on this mediation and the physicians who treated them often express confidence in this medication. But, this can’t be a blanket indicator for a new patient to consider using it.
Blinatumomab is commercially available as Blincyto 38.5mcg vials. Promoted by Amgen, this drug is approved and accessible in countries including USA, European and some Middle Eastern countries. This is a cold chain medication which has to be stored, transported and delivered in constant temperature conditions of 2 to 8 Degrees. The ongoing research and emerging data indicate the growing relevance of Blincyto.
Speciality drugs that are newly approved by FDA that are also not available in India have to be legally imported. This can be initiated based on the recommendation of your treating physician. Haematologists are authorised to prescribe this medication.
Depending on your prescribed dosage, you can apply for a patient specific license or import permit from CDSCO. You can procure the permit for the entire quantity required for all the cycles, which will be valid for a period of six months.
Blincyto in India for import requires you to work with a reliable global supplier or company that can process the export from any of the counties this drug is available. This is an important phase which determines the time taken for the import process.
The entire process for importing cold chain medications is different, often times little complex. For this reason, you should be more aware of the pros and cons of engaging the right kind of sources. Always ensure you make the payments only through banking channels. It is both safe and legal too.
By the time your supplier ships the medicines from the designated country of import, you have to complete the documentation that is specific to Indian customs. Once the necessary clearance formalities are complete, you can expect doorstep delivery of Blinatumomab India.
1. You are probably aware of the fact that Blincyto is a costly medication and is very crucial for your health. Therefore you must be extra careful in verifying the genuineness of the suppliers you talk to.
2. You need to ensure proper legal documents are submitted by your supplier who ensures the import is officially done, exclusively for the patient based on the import permit.
3. You would require a legal or commercial invoice which also indicates the batch numbers of the medicines delivered to you. You should also cross check the Bill of Entry from Indian Customs for your satisfaction.
Synergy Drugs always engage experienced professionals who have adequate know-how about the legal process of import for patients benefit. Drugs like Blinatumomab in India that are imported for specific patient requirement are meant to help improve their health condition. You can absolutely rely on us to connect you with reliable global sources.